Ikarian Capital, LLC Agios Pharmaceuticals, Inc. Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 125,000 shares of AGIO stock, worth $6.72 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
125,000Holding current value
$6.72 Million% of portfolio
0.22%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
234Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$304 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$298 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$261 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$201 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$152 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.95B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...